Abstract
Atherosclerotic cardiovascular disease (CVD) leading to coronary heart disease is the leading cause of morbidity and mortality in the world. Nutrition is one of the key factors in the etiology of atherosclerosis. Micronutrient supplements are widely used to prevent many chronic diseases including atherosclerosis. However, scientific evidence regarding this issue is still insufficient and current data on the association of dietary micronutrients and CVD risk is contradictory. Most of the randomized studies have failed to demonstrate beneficial effects of micronutrient supplementation on markers of subclinical atherosclerosis. In this review, role of each micronutrient on subclinical atherosclerosis will be evaluated thoroughly.
Keywords: Subclinical atherosclerosis, flow-mediated dilatation, carotid intima-media thickness, coronary artery calcium score, pulse wave velocity, vitamins, minerals, micronutrients.
Current Pharmaceutical Design
Title:Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis
Volume: 22 Issue: 2
Author(s): Duygu Kocyigit, Kadri Murat Gurses, Muhammed Ulvi Yalcin and Lale Tokgozoglu
Affiliation:
Keywords: Subclinical atherosclerosis, flow-mediated dilatation, carotid intima-media thickness, coronary artery calcium score, pulse wave velocity, vitamins, minerals, micronutrients.
Abstract: Atherosclerotic cardiovascular disease (CVD) leading to coronary heart disease is the leading cause of morbidity and mortality in the world. Nutrition is one of the key factors in the etiology of atherosclerosis. Micronutrient supplements are widely used to prevent many chronic diseases including atherosclerosis. However, scientific evidence regarding this issue is still insufficient and current data on the association of dietary micronutrients and CVD risk is contradictory. Most of the randomized studies have failed to demonstrate beneficial effects of micronutrient supplementation on markers of subclinical atherosclerosis. In this review, role of each micronutrient on subclinical atherosclerosis will be evaluated thoroughly.
Export Options
About this article
Cite this article as:
Kocyigit Duygu, Gurses Murat Kadri, Yalcin Ulvi Muhammed and Tokgozoglu Lale, Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis, Current Pharmaceutical Design 2016; 22 (2) . https://dx.doi.org/10.2174/1381612822666151112150020
DOI https://dx.doi.org/10.2174/1381612822666151112150020 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design Long-Term Bronchodilator Inhaled Therapy in COPD: The Role of Tiotropium Bromidum
Reviews on Recent Clinical Trials Fibrin Clot Properties and Cardiovascular Disease
Vascular Disease Prevention (Discontinued) The Promotion of Mental Health: Role of the Family
Adolescent Psychiatry L-Dopa Related Hyperhomocysteinemia: A Possible Mediator of Toxicity?
Letters in Drug Design & Discovery Pre-CKD- Do we Need Another Hero?
Current Vascular Pharmacology MicroRNA Therapeutics for Cardiac Regeneration
Mini-Reviews in Medicinal Chemistry Treatment of Fabry Disease: Current and Emerging Strategies
Current Pharmaceutical Biotechnology Antioxidant Therapy for the Treatment of Oxidative Stress Associated to Cancer and Cancer- Related Anorexia/Cachexia
Current Nutrition & Food Science Stroke and Neuroinflamation: Role of Sexual Hormones
Current Pharmaceutical Design Cocaine and Acute Vascular Diseases
Current Drug Abuse Reviews Heart Failure Models: Traditional and Novel Therapy
Current Vascular Pharmacology Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
Current Pharmaceutical Design Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy
Recent Patents on Anti-Cancer Drug Discovery Acute Physical Stress Increases Serum Levels of Specific microRNAs
MicroRNA Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase
CNS & Neurological Disorders - Drug Targets Lifestyle Modifications in the Treatment of Hypertension
Current Hypertension Reviews Weight Loss in Obesity and Metabolic Syndrome
Current Hypertension Reviews The Prevalence, Morbidities, and Treatments of Insomnia
CNS & Neurological Disorders - Drug Targets Inflammation in Fish As Seen from A Morphological Point of View with Special Reference to the Vascular Compartment
Current Pharmaceutical Design